Oxford Expression Technologies Launch Streamlined Transfection Technology
Oxford Expression Technologies (OET), the award-winning specialist provider of baculovirus-based protein expression solutions, launches flashFECTIN™, a transfection reagent optimized for insect cell lines. Used in conjunction with the world renowned flashBAC™ system, the new reagent represents significant improvements with respect to ease of use, speed and affordability.
- (1888PressRelease) May 14, 2013 - Oxford, UK - Co-transfections can be troublesome and time consuming, flashFECTIN™ has been specifically designed to address these issues, the co-transfection protocol has been highly streamlined to allow the fastest flashBAC™ reaction times to date whilst still maintaining the high efficiencies expected from the flashBAC™ system. The new transfection reagent is a non-lipid based formulation that is non-toxic to cells and is specifically optimized for insect cell lines Sf9, Sf21 and Tni.
Passing comment, James Bernard, Commercial Director at Oxford Expression Technologies said, "We are pleased to announce the launch of flashFECTIN™, our new transfection reagent to further improve the flashBAC™ system" he continued, "we are delighted that our customers can now benefit from a more affordable system with a faster and simplified protocol that still produces the same high transformation efficiencies."
Oxford Expression Technologies invites anyone with an interest in baculovirus protein expression to visit their website - http://oetltd.com/
Oxford Expression Technologies is a biotechnology company specializing in the use of baculovirus vectors, a eukaryotic expression system that can express a large variety of recombinant proteins. Oxford Expression Technologies provides recombinant protein expression products, services and consultancy to many global pharmaceutical companies. The Company's proprietary flashBAC technology enables large amounts of a given protein to be produced in culture. Its internationally renowned expertise and products enable proteins to be produced faster, more easily and cost-effectively using automated and high-throughput methods compared with other baculovirus expression systems. This contributes to the development of new drugs and research targeted towards understanding how proteins work in health and disease.
The company was founded in 2007 as a result of collaboration between Oxford Brookes University and the Natural Environment Research Council to provide researchers with custom proteins for research purposes.
For Further information or an illustrative image:
Media contact - Mathew Taylor, Director, Algorythm Solutions Ltd, mobile: +44 (0)773 403 2112, email: mtaylor ( @ ) algorythmsolutions dot com, website: www dot algorythmsolutions dot com
Contact:
Mathew Taylor
Director
Algorythm Solutions Ltd
10 Torkington St
Stamford, Lincolnshire PE9 2UY
+44 (0)773 403 2112
mtaylor ( @ ) algorythmsolutions dot com
http://www.algorythmsolutions.com
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam